# A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults

> **NCT03597217** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-05221304
- **DRUG:** PF-05221304
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03597217
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-27
- **Primary completion:** 2018-11-15
- **Final completion:** 2018-11-15
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03597217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03597217, "A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03597217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*